C4PAIN ApS: Financial statements 2017
CVR: 32292402
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
C4PAIN ApS (CVR 32292402) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK 665,845 and a net result of DKK 659,611 compared with DKK -373,938 the year before. Equity in the 2017 report amounted to DKK 811,766. The solvency ratio was 99%.
- Gross Profit
- DKK 665,845
- Profit/Loss
- DKK 659,611
- Equity
- DKK 811,766
- Total Assets
- DKK 819,765
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | 666 t. | 660 t. | 812 t. | - |
| 2016 | - | -453 t. | -374 t. | 152 t. | - |
| 2015 | - | -405 t. | -235 t. | 526 t. | - |
| 2014 | - | 285 t. | 241 t. | 761 t. | - |
| 2013 | - | -448 t. | 1.6 mio. | 520 t. | - |
Official annual report
Keep an eye on C4PAIN ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
C4PAIN ApS has published its annual report for 2016. Gross profit came to DKK -453,434, and the net result was DKK -373,938.
About C4PAIN ApS
C4PAIN ApS is a Danish company of the type Anpartsselskab based in Aalborg, founded in 2009. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Lars Arendt-Nielsen. The company is owned by BIO-MEDICAL CONSULT HOLDING ApS. The company has 0 employees (2014). In 2025, the company reported a gross profit of DKK 159,243 and a net result of DKK 185,909 compared with DKK 1,074,600 the year before. Equity in the 2025 report amounted to DKK 4,164,765.